MAP1B and attention deficit-hyperactivity disorder: Pathogenic variants in the <i>MAP1B</i> gene have been associated with neurological impairment, including intellectual disability, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, brain malformations, cognitive hearing loss, short stature, and dysmorphic features.